Plumbline Life Sciences, Inc. (XKON:222670)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,940.00
-30.00 (-0.50%)
At close: Apr 17, 2025, 3:30 PM KST
-0.67%
Market Cap 20.27B
Revenue n/a
Net Income n/a
Shares Out 3.33M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,502
Average Volume 5,112
Open 6,190.00
Previous Close 5,970.00
Day's Range 5,810.00 - 6,190.00
52-Week Range 3,360.00 - 7,950.00
Beta 0.44
RSI 51.30
Earnings Date n/a

About Plumbline Life Sciences

Plumbline Life Sciences, Inc. engages in the development and sale of DNA medicines for animals. Its products include LifeTide SW5, a pig immune-modulator; PLS-ASF, a swine fever DNA vaccine; PLS-FMD; PLS-B3000, a dairy cattle DNA therapy; PLS-IF1000, a FMD vaccine; PLS-H1000, a horse laminitis therapy; PLS-D5000, a dog DNA cancer immunotherapy; PLS-D1000 for age related immune deficiency in senior dogs; and PLS-C2000 for age related immune deficiency in senior cats. Plumbline Life Sciences, Inc. was founded in 2014 and is headquartered in Seoul... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 222670
Full Company Profile

News

There is no news available yet.